Jain Global’s Novo Nordisk NVO Stock Holding History

Jain Global’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.79M	Hold	100,000	–	–	0.02%	581
2026 Q1	$3.67M	Buy	+100,000	New	+$4.74M	0.02%	550

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jain Global's NVO Position: Q2 2026 in Review

Jain Global sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 17,890 shares — an estimated $769K sold.

Jain Global first reported a position in NVO in Q1 2025 and held it in 5 quarters. The position peaked at $11.1M in Q4 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Jain Global reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
Jain Global sold 17,890 Novo Nordisk shares in Q2 2026, an estimated $769K.
Jain Global first reported a position in Novo Nordisk in Q1 2025 and held it in 5 quarters.
Jain Global's Novo Nordisk position peaked at $11.1M in Q4 2025.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.